Erschienen in:
01.08.2019 | ASO Author Reflections
ASO Author Reflections: Current State of Surgical Sarcopenia in Esophageal Cancer
verfasst von:
Shion Uemura, MD, Toshiaki Shichinohe, MD, PhD, Masao Hosokawa, MD, PhD, Satoshi Hirano, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Sonderheft 3/2019
Einloggen, um Zugang zu erhalten
Excerpt
The psoas muscle index (PMI) or skeletal muscle index can be calculated using the psoas muscle area or the skeletal muscle area of the lumbar third vertebra, with computed tomography (CT) used to measure the skeletal muscle mass ratio of the body.
1,2 Some previous reports
3‐
5 have used these indexes for definitions of sarcopenia, showing that short- and long-term outcomes after esophagectomy are significantly worse in sarcopenic patients with esophageal cancer (EC). But cutoff points of muscle indexes in these reports were not unified, and criteria for “surgical sarcopenia” are not defined to date. Esophagectomy is a highly advanced invasive operation. Thus, esophagectomy generally is not indicated for “pure” sarcopenic patients, as defined by the European Working Group for Sarcopenia in Older People
6 or the Asian Working Group for Sarcopenia.
7 Therefore, composite analysis of preoperative factors such as age, body mass index (BMI), hemoglobin, and the like, which are known to be associated with sarcopenia,
8,9 including skeletal muscle mass indexes, is necessary for an evaluation of surgical risk for EC patients. …
